Tumour cell expression of interleukin 6 receptor α is associated with response rates in patients treated with sunitinib for metastatic clear cell renal cell carcinoma

Clear cell renal cell carcinoma (ccRCC) is the most common type of renal cell carcinoma, and anti‐angiogenic treatment is currently first line therapy for metastatic ccRCC (mccRCC). Response rates and duration of response show considerable variation, and adverse events have a major influence on pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Pilskog, Martin, Bostad, Leif, Edelmann, Reidunn J, Akslen, Lars A, Beisland, Christian, Straume, Oddbjørn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5903692/
https://www.ncbi.nlm.nih.gov/pubmed/29665322
http://dx.doi.org/10.1002/cjp2.96

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5903692/
https://www.ncbi.nlm.nih.gov/pubmed/29665322
http://dx.doi.org/10.1002/cjp2.96

Ejemplares similares